AIDS and Behavior

, Volume 18, Issue 4, pp 716–725 | Cite as

Increasing Quality of Life and Reducing HIV Burden: The PATH+ Intervention

  • Michael B. Blank
  • Michael Hennessy
  • Marlene M. Eisenberg
Original Paper

Abstract

The heightened risk of persons with serious mental illness (SMI) to contract and transmit human immunodeficiency virus (HIV) is a public health problem. Our objective was test the effectiveness of a community-based advanced practice nurse intervention to promote adherence to HIV and psychiatric treatment regimens call Preventing AIDS Through Health for Positives (PATH+). We enrolled 238 HIV-positive subjects with SMI who were in treatment at community HIV provider agencies from 2004 to 2009. Participants in the intervention group were assigned an advanced practice nurse who provided community-based care management at a minimum of one visit/week and coordinated their medical and mental healthcare for 12 months. A parallel process latent growth curve model using three data points for biomarkers (baseline, 12 and 24 months) and five data points for health related quality of life (baseline, 3, 6, 12, and 24 months) showed moderate to excellent fit for modeling changes in CD4, viral load, and mental and physical SF-12 subscales. Results suggest that positive effects for PATH+ persisted at 24 months; 12 months after the intervention ended. This project demonstrates the effectiveness of a nurse-led, community-based, individually tailored adherence intervention. We demonstrated improved outcomes in individuals with HIV/SMI and regarding health-related quality of life and reductions in disease burden.

Keywords

HIV and serious mental illness Syndemic illness Structural equation modeling Parallell process latent growth curve modeling Heath-related quality of life Biomarkers for HIV/AIDS intervention effectiveness 

References

  1. 1.
    Gottesman I, Groome CS. HIV/AIDS risks as a consequence of schizophrenia. Schizophr Bull. 1997;23(4):675–84.PubMedCrossRefGoogle Scholar
  2. 2.
    Walkup J, Blank MB, Gonzalez JS, et al. The impact of mental health and substance abuse factors on HIV prevention and treatment. J Acquir Immune Defic Syndr. 2008;47:S15–9.PubMedCrossRefGoogle Scholar
  3. 3.
    Blank MB, Eisenberg MM. HIV and mental illness: opportunities for prevention. Journal of prevention & intervention in the community. J Prev Interv. 2007;33(1–2):1–4.CrossRefGoogle Scholar
  4. 4.
    Susser E, Valencia E, Conover S. Prevalence of HIV-infection among psychiatric patients in a New York City men’s shelter. Am J Public Health. 1993;83(4):568–70.PubMedCentralPubMedCrossRefGoogle Scholar
  5. 5.
    Blank MB, Mandell DS, Aiken L, Hadley TR. Co-occurrence of HIV and serious mental illness among medicaid recipients. Psychiatric services. 2002;53(7):868–73.PubMedCrossRefGoogle Scholar
  6. 6.
    Himelhoch S, McCarthy JF, Ganoczy D, Medoff D, Dixon LB, Blow FC. Understanding associations between serious mental illness and HIV among patients in the VA health system. Psychiatr Serv. 2007;58(9):1165–72.PubMedCrossRefGoogle Scholar
  7. 7.
    Rothbard A, Blank M, Staab J, et al. Previously undetected metabolic syndromes and infectious diseases among psychiatric inpatients. Psychiatr Serv. 2009;60(4):534–7.PubMedCrossRefGoogle Scholar
  8. 8.
    Parry CD, Blank MB, Pithey AL. Responding to the threat of HIV among persons with mental illness and substance abuse. Curr Opin Psychiatr. 2007;20(3):235–41.Google Scholar
  9. 9.
    Blank MB, Hanrahan NP, Fishbein M, et al. A randomized trial of a nursing intervention for HIV disease management among persons with serious mental illness. Psychiatr Serv. 2011;62(11):1318–24.PubMedCrossRefGoogle Scholar
  10. 10.
    Walkup J, Blank MB, Gonzalez JS, et al. The impact of mental health and substance abuse factors on HIV prevention and treatment. J Acquir Immune Defic Syndr. 2008;47:S15–9.PubMedCrossRefGoogle Scholar
  11. 11.
    Drake RE. Brief history, current status, and future place of assertive community treatment. Am J Orthopsychiatry. 1998;68(2):172–5.PubMedCrossRefGoogle Scholar
  12. 12.
    Lee AK, Hanrahan NP, Aiken LH, Blank MB. Perceived facilitators and barriers to the implementation of an advanced practice: nursing intervention for HIV regimen adherence among the seriously mentally ill. J Psychiatr Ment Health Nurs. 2006;13(5):626–8.PubMedCrossRefGoogle Scholar
  13. 13.
    Morgan BD, Rossi AP. Difficult-to-manage HIV/AIDS clients with psychiatric illness and substance abuse problems: a collaborative practice with psychiatric advanced practice nurses. J Assoc Nurses AIDS Care. 2007;18(6):77–84.PubMedCrossRefGoogle Scholar
  14. 14.
    Kane CF, Blank MB. NPACT: enhancing programs of assertive community treatment for the seriously mentally Ill. Community Ment Health J. 2004;40(6):549–59.PubMedCrossRefGoogle Scholar
  15. 15.
    Aiken L, Lake E, Semaan S, et al. Nurse practitioner managed care for persons with HIV infection. J Nurs Scholarsh. 1993;25(3):172–7.CrossRefGoogle Scholar
  16. 16.
    Battaglioli-DeNero AM. Strategies for improving patient adherence to therapy and longterm patient outcomes. J Assoc Nurses AIDS Care. 2007;18(1 Suppl):S17–22.PubMedCrossRefGoogle Scholar
  17. 17.
    Collins L, Murphy S, Bierman K. A conceptual framework for adaptive preventive interventions. Prev Sci. 2004;5(3):185–96.PubMedCentralPubMedCrossRefGoogle Scholar
  18. 18.
    Blank MB, Eisenberg MM. Tailored treatment for HIV + persons with mental illness: the intervention cascade. J Acquir Immune Defic Syndr. 2013;63:S44–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Ware JE Jr, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of Scales and Preliminary Tests of Reliability and Validity. Med Care. 1996;34(3):220–33.PubMedCrossRefGoogle Scholar
  20. 20.
    Salyers MP, Bosworth HB, Swanson JW, Lamb-Pagone J, Osher FC. Reliability and Validity of the SF-12 Health Survey among People with Severe Mental Illness. Med Care. 2000;38(11):1141–50.PubMedCrossRefGoogle Scholar
  21. 21.
    Curran P, Hussong A. Structural equation modeling of repeated measures data: latent curve analysis. In: Moskowitz D, Hershberger S, editors. Modeling intraindividual variability with repeated measures data. Mahwah: Lawrence Erlbaum; 2002. p. 59–85.Google Scholar
  22. 22.
    Curran P, Muthén B. The application of latent curve analysis to testing developmental theories in intervention research. Am J Community Psychol. 1999;27:567–95.PubMedCrossRefGoogle Scholar
  23. 23.
    Fergus S, Zimmerman M, Caldwell CH. Growth trajectories of sexual risk behavior in adolescence and young adulthood. Am J Public Health. 2007;97:1096–101.PubMedCentralPubMedCrossRefGoogle Scholar
  24. 24.
    Barnes G, Reifman A, Farrell M, Dintcheff B. The effects of parenting on the development of adolescent alcohol misuse: a six-wave latent growth model. J Marriage Family. 2000;62:175–86.CrossRefGoogle Scholar
  25. 25.
    Fishbein M, Hennessy M, Kamb M, et al. Using intervention theory to model factors influencing behavior change. Project RESPECT. Eval Health Prof. 2001;24(4):363–84.PubMedCrossRefGoogle Scholar
  26. 26.
    Bollen K, Curran P. Latent curve models. New York: Wiley; 2006.Google Scholar
  27. 27.
    Cheong J, MacKinnon DP, Khoo ST. Investigation of mediational processes using parallel process latent growth curve modeling. Struct Equ Modeling. 2003;10(2):238–62.PubMedCentralPubMedCrossRefGoogle Scholar
  28. 28.
    Biesanz J, Deeb-Sossa N, Papadakis A, Bollen K, Curran P. The role of coding time in estimating and interpreting growth curve models. Psychol Methods. 2004;9(1):30–52.PubMedCrossRefGoogle Scholar
  29. 29.
    Hu L-T, Bentler P. Evaluating model fit. In: Hoyle R, editor. Structural equation modeling: Concepts, issues and applications. Newbury Park: Sage; 1995. p. 76–99.Google Scholar
  30. 30.
    Koblin B, Chesney M, Coates T. Effects of a behavioral intervention to reduce acquisition of HIV infection among men who have sex with men: the EXPLORE randomized controlled study. Lancet. 2004;364:41–50.PubMedCrossRefGoogle Scholar
  31. 31.
    Belcher L, Kalichman S, Topping M, et al. A randomized trial of a brief HIV risk reduction counseling intervention for women. J Consult Clin Psychol. 1998;66(5):856–61.PubMedCrossRefGoogle Scholar
  32. 32.
    Cottler L, Compton W, Abdahllah A, Cunningham-Williams R, Abram F, Fichtenbaum C. Peer delivered interventions reduce HIV risk behaviors among out-of-treatment drug abusers. Public Health Rep. 1998;113:58–66.Google Scholar
  33. 33.
    Stephens RC, Simpson DD, Coyle SL, McCoy CB. Comparative effectiveness of NADR interventions. In: Brown BS, Beschner GM, editors. Handbook on risk of AIDS. Westport: Greenwood Press; 1993. p. 519–56.Google Scholar
  34. 34.
    Friedman SR, Jose B, Deren S, Des Jarlais DC, Neaigus A. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. Am J Epidemiol. 1995;142(8):864–74.PubMedGoogle Scholar
  35. 35.
    Gibson DR, McCusker J, Chesney M. Effectiveness of psychosocial interventions in preventing HIV risk behaviour in injecting drug users. AIDS. 1998;12(8):919–29.PubMedCrossRefGoogle Scholar
  36. 36.
    Coyle S, Needle R, Normand J. Outreach based HIV prevention for injecting drug users: a review of published outcome data. Public Health Rep. 1998;113(Supplement 1):19–30.PubMedCentralPubMedGoogle Scholar
  37. 37.
    Lightfoot M, Rotheram-Borus MJ, Comulada S, Gundersen G, Reddy V. Self-monitoring of behaviour as a risk reduction strategy for persons living with HIV. AIDS Care. 2007;19(6):757–63.PubMedCrossRefGoogle Scholar
  38. 38.
    Mannheimer SB, Morse E, Matts JP, et al. Sustained benefit from a long-term antiretroviral adherence intervention: results of a large randomized clinical trial. J Acquir Immune Defic Syndr. 2006;43:S41–7.PubMedCrossRefGoogle Scholar
  39. 39.
    Holzemer WL, Bakken S, Portillo CG. Testing a nurse-tailored HIV medication adherence intervention. Nurs Res. 2006;55:189–97.PubMedCrossRefGoogle Scholar
  40. 40.
    Rotheram-Borus MJ, Swendeman D, Chovnick G. The past, present, and future of HIV prevention: integrating behavioral, biomedical, and structural intervention strategies for the next generation of HIV prevention. Annu Rev Clin Psychol. 2009;5:143.PubMedCentralPubMedCrossRefGoogle Scholar
  41. 41.
    Katon WJ, Lin EH, Von Korff M, et al. Collaborative care for patients with depression and chronic illnesses. N Engl J Med. 2010;363(27):2611–20.PubMedCentralPubMedCrossRefGoogle Scholar
  42. 42.
    Marziali M, De Santis W, Carello R, et al. T-cell homeostasis alteration in HIV-1 infected subjects with low CD4 T-cell count despite undetectable virus load during HAART. AIDS. 2006;20(16):2033–41.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  • Michael B. Blank
    • 1
    • 2
  • Michael Hennessy
    • 2
  • Marlene M. Eisenberg
    • 3
  1. 1.Center for Mental Health Policy and Services ResearchUniversity of PennsylvaniaPhiladelphiaUSA
  2. 2.Annenberg Public Policy CenterUniversity of PennsylvaniaPhiladelphiaUSA
  3. 3.HIV/AIDS Prevention Research DivisionUniversity of PennsylvaniaPhiladelphiaUSA

Personalised recommendations